Abstract:Spinal cord injury (SCI) can lead to severe motor and sensory dysfunction, with a high rate of disability and mortality. Due to the complicated pathological process of SCI, there is no effective clinical treatment strategy at present. Although mesenchymal stem cells (MSCs) are effective in the treatment of SCI, their application is limited by factors such as low survival rate, cell dedifferentiation, tumorigenesis, blood-brain barrier, and immune rejection. Fortunately, there is growing evidence that most of the biological and therapeutic effects of MSCs may be mediated by the release of paracrine factors, which are extracellular vesicles called exosomes. Exosomes are small endosomal vesicles with bilaminar membranes that have recently been recognized as key mediators for communication between cells and tissues through the transfer of proteins, lipids, nucleic acids, cytokines, and growth factors. Mesenchymal stem cell-derived exosomes (MSC-exos) play a critical role in SCI repair by promoting angiogenesis and axonal growth, regulating inflammation and immune response, inhibiting apoptosis, and maintaining the integrity of the blood-spinal cord barrier. Furthermore, they can be used to transport genetic material or drugs to target cells, and their relatively small size allows them to permeate the blood-brain barrier. Studies have demonstrated that some exosomal miRNAs derived from MSCs play a significant role in the treatment of SCI. In this review, we summarize recent research advances in MSC-exos and exosomal miRNAs in SCI therapy to better understand this emerging cell-free therapeutic strategy and discuss the advantages and challenges of MSC-exos in future clinical applications.

[Research Advances in Mesenchymal Stem Cell-Derived Exosomes in Treatment of Brain Injury].

A Prosperous Application of Hydrogels with Extracellular Vesicles Release for Traumatic Brain Injury

Emerging potential of exosomes for treatment of traumatic brain injury

Neural stem cell-derived exosomes and regeneration: cell-free therapeutic strategies for traumatic brain injury

Therapeutic Potential of Mesenchymal Stem Cell-Derived Exosomes in Spinal Cord Injury

The application of mesenchymal stem cells in the treatment of traumatic brain injury: Mechanisms, results, and problems

The Role of Exosomes from Mesenchymal Stem Cells in Spinal Cord Injury: A Systematic Review

Non-stem cell-derived exosomes: a novel therapeutics for neurotrauma

Research Progresses in the Inhibitory Effect of Bone Mesenchymal Stem Cell-Derived Exosome on Blood-Brain Barrier Disruption following Intracerebral Hemorrhage in Rats

Exosomes Derived from Mesenchymal Stem Cells: Therapeutic Opportunities for Spinal Cord Injury

Engineered exosomes enriched with select microRNAs amplify their therapeutic efficacy for traumatic brain injury and stroke

Emerging Role of Mesenchymal Stem Cell-derived Exosomes in Regenerative Medicine

Mesenchymal stem cell-derived exosomes: therapeutic opportunities and challenges for spinal cord injury

Mesenchymal stem cell-derived exosomes regulate microglia phenotypes: a promising treatment for acute central nervous system injury

Novel Therapeutic Applications of Stem Cell-Derived Exosomes in Enhancing Neurological Regeneration and Repair

Unraveling the Emerging Niche Role of Extracellular Vesicles (EVs) in Traumatic Brain Injury (TBI)

Mesenchymal Stem Cell–Derived Exosomes Improve Functional Recovery in Rats After Traumatic Brain Injury: A Dose-Response and Therapeutic Window Study

Study on Immune Regulation of Bone Marrow Mesenchymal Stem Cell-Derived Exosomes in Preterm Infants with Brain Injury

Bone Marrow Mesenchymal Stem Cell-Derived Exosomes Improves Spinal Cord Function after Injury in Rats by Activating Autophagy

Mesenchymal stem cell-derived exosomes as a new drug carrier for the treatment of spinal cord injury: A review

MSC-derived exosomes promote recovery from traumatic brain injury via microglia/macrophages in rat